roflumilast
arcutis,astrazeneca
['derm', 'roflumilast', 'arcutis', '$arqt']
$arqt new data from arcutis' stratum pivotal phase 3 trial of roflumilast foam 0.3% in seborrheic dermatitis presented at european academy of dermatology and venereology (eadv) congress 
GetOnTrade is a news platform to help you stay up-to-date with the latest stock market news. We are not financial advisor(please do your own due diligence).